参考文献

［1］MIROWSKI M，REID PR，MOWER MM，et al.Termination of malignant ventricular arrhythmias with an implanted automatic def i brillator in human beings.N Engl J Med，1980，303：322-324.

［2］MOSS AJ，ZAREBA W，HALL WJ，et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.N Engl J Med，2002，346：877-883.

［3］KLEEMANN T，BECKER T，DOENGES K，et al.Annual rate of transvenous def i brillation lead defects in implantable cardioverter-def i brillators over a period of＞10 years.Circulation，2007，115：2474-2480.

［4］LURIA D，GLIKSON M，BRADY PA，et al.Predictors and mode of detection of transvenous lead malfunction in implantable def i brillators.Am J Cardiol，2001，87：901-904.

［5］BARDY GH，LEE KL，MARK DB，et al.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.N Engl J Med，2005，352：225-237.

［6］WAZNI O，EPSTEIN LM，CARRILLO RG，et al.Lead extraction in the contemporary setting：the LExICon study：an observational retrospective study of consecutive laser lead extractions.J Am Coll Cardiol，2010，55：579-586.

［7］WILKOFF BL，OUSDIGIAN KT，STERNS LD，et al.A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators：results from the prospective randomized multicenter EMPIRIC trial.J Am Coll Cardiol，2006，48：330-339.

［8］LARIA D，GLIKSON M，BRADY PA，et al.Predictors and mode of detection of transvenous lead malfunctionin implantable def i brillators.Am J Cardiol，2001，87：901-904.

［9］BARDY GH，SMITH WM，HOOD MA，et al.An entirely subcutaneous implantable cardioverterdef i brillator.N Engl J Med，2010，363：36-44.

［10］NIEBAUER MJ，WILKOFF B，YAMANOUCHI Y，et al.Indium oxide-coated def i brillation electrode，reduced shock polarization and improve def i brillation eff i cacy.Circulation，1997，96：3732-3736.

［11］WAZNI O，EPSTEIN LM，CARRILLO RG，et al.Lead extraction in the contemporary setting：the Lexicon Study：an observational retrospective study of consecutive laser lead extractions.J Am Coll Cardiol，2010，55：579-586.

［12］SAEED M，NEASON CG，RAZAVI M，et al.Progamming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators：results from the PROVE trial.J Cardiovasc Electrophysiol，2010，21：1349-1354.

［13］SCHWAB JO.Optimizing ICD progamming for shock reduction.Fundam Clin Pharmacol，2010，24：653-659.

［14］BARDY GH，SMITH WM，HOOD MA，et al.An entirely subcutaneous implantable cardioverterdef i brillator.N Engl J Med，2010，363：36-44.

［15］UNTEREKER DF.The use of a microcalorimeter for analysis of load dependent processes occurring in a primary battery.J Electrochem Soc，1978，125：1907.

［16］WILKOFF BL，FAUCHIER L，STILES MK，et al.2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.J Arrhythmia，2016，32（1）：1-28.